Author Profile

Lee Peart

Lee Peart

Editor of Healthcare Management

Articles by Lee Peart

Streeting explains why he voted against assisted dying

By Lee Peart 23 June 2025

Health and social care secretary Wes Streeting has explained why he voted against assisted dying legislation in the House of Commons on Friday.

Trust told to make immediate improvements to maternity and neonatal care

By Lee Peart 20 June 2025

Leeds Teaching Hospitals NHS Trust has been told to make immediate improvements to its maternity and neonatal services.

North Bristol NHS Trust awarded £1.56m in research funding

By Lee Peart 20 June 2025

North Bristol NHS Trust (NBT) has received £1.56m in Research Capability Funding (RCF) from the NIHR for 2025/26.

MPs to vote on Assisted Dying Bill

By Lee Peart 20 June 2025

MPs will today vote on the final stage of The Terminally Ill Adults (End of Life) Bill in the House of Commons.

NHS waiting times rise in Wales

By Lee Peart 19 June 2025

The number of people waiting over two years for treatment rose by 14% to 9,600 in Wales in April.

BREAKING NEWS: NHS to receive £6bn a year under 10-Year Infrastructure Strategy

By Lee Peart 19 June 2025

Over £6bn a year is to be used to create safer hospital environments under plans announced by the Treasury today.

Trust 'deeply sorry' following complaints of inadequate maternity care

By Lee Peart 19 June 2025

The Leeds Teaching Hospitals NHS Trust has said it is ‘deeply sorry’ following complaints about its maternity care.

Trust apologises after investigation reveals care failings

By Lee Peart 19 June 2025

An apology has been issued by North East London NHS Foundation Trust (NELFT) over care failings following an investigation.

Police begin staff interviews in maternity services investigation

By Lee Peart 19 June 2025

West Mercia Police is to begin interviews of current and former staff as part of an investigation into maternity services at The Shrewsbury and Telford Hospital NHS Trust.

Alzheimer's drug benefits 'too small' to offer on NHS, NICE finds

By Lee Peart 19 June 2025

The benefits from Alzheimer’s drugs donanemab and lecanemab are too small to justify the additional costs to the NHS, NICE has found.